Prilenia is dedicated to developing new treatments for the urgent needs facing patients and families with Huntington’s disease, amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases
Prilenia is dedicated to developing new treatments for the urgent needs facing patients and families with Huntington’s disease, amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.